Once-weekly Semaglutide shows Consistent HBA1C Reductions and Weight Loss compared to Sitagliptin supriya kashyap kashyap16 April 2017 10:20 AM ISTFindings from a post hoc analysis of the phase 3a SUSTAIN 2-4 trials demonstrated greater mean reductions in HbA1c and body weight with once-weekly...
Semaglutide -New once-weekly option for Type 2 diabetes approved Dr. Kamal Kant Kohli Kohli5 Dec 2017 7:25 PM ISTEndocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.S. Food and Drug Administration (FDA) approved once-weekly semaglutide to...
Semaglutide causes greater reductions in HbA1c, body weight compared with Dulaglutide Medical Dialogues Bureau3 Feb 2018 8:30 PM ISTAccording to results of 40-week SUSTAIN 7 trial Published in The Lancet Diabetes & Endocrinology, patients of type 2 diabetes treated with...
New Anti-Obesity pill that causes highest weight reduction Dr. Kamal Kant Kohli Kohli18 March 2018 8:00 PM ISTObesity is a major public health problem globally and is a leading cause of morbidity, compromised quality of life and increasing healthcare costs....
SGLT-2 inhibitors best for lowering mortality risk in T2DM : JAMA Dr. Kamal Kant Kohli Kohli22 April 2018 8:00 PM ISTThe comparative clinical efficacy of sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like peptide 1 (GLP-1) agonists, and dipeptidyl...
Oral semaglutide better than empagliflozin in improving HbA1c -PIONEER 2 trial Vinay Singh singh3 Jun 2018 8:25 PM ISTTreatment with oral semaglutide 14mg led to a statistically significant improvement in hemoglobin A1c (HbA1c) levels and weight loss in adults with...
Semaglutide manages diabetes and weight better than other GLP-1 receptor agonists Medha Baranwal Baranwal18 Aug 2018 8:10 PM ISTSwitching to semaglutide, a GLP-1 analog, from another GLP-1 receptor agonists (such as liraglutide, dulaglutide or exenatide) resulted in a further...
Oral semaglutide effective in diabetes with renal impairment: PIONEER 5 trial Medha Baranwal Baranwal24 Aug 2018 7:10 PM ISTThe pharmaceutical company Novo Nordisk has revealed that based on the results from Phase 3a PIONEER 5 trial, oral semaglutide has hit the mark in the...
Study identifies diabetes drugs that are effective in diabetic retinopathy Medha Baranwal Baranwal29 July 2019 7:30 PM ISTSydney, Australia: A recent review published in the journal Eye has thrown light on the non-insulin anti-hyperglycemic agents used for the treatment...
Type 2 diabetes: Oral Semaglutide does not increase CVD risk Medha Baranwal Baranwal17 Sept 2019 8:55 AM ISTCanada: Oral semaglutide does not increase cardiovascular risk in patients with type 2 diabetes, according to a recent study published in The New...
FDA approves first ever oral Semaglutide for blood sugar control in type 2 diabetes Dr. Kamal Kant Kohli Kohli20 Sept 2019 8:20 PM ISTFood and Drug Administration has approved first GLP-1 oral drug Semaglutide for blood sugar control in type 2 diabetes.The U.S. Food and Drug...
Add on semaglutide leads to better blood sugar control compared to canagliflozin in diabetes: Lancet Dr. Kamal Kant Kohli Kohli21 Sept 2019 9:05 AM ISTIn cases where blood sugar and glycated hemoglobin is not controlled properly with Metformin alone, it is endeavor of treating doctors to add diabetes...
